3 studies found for:    21989902 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Condition: HER2 Low to Intermediate Breast Cancer
Interventions: Biological: NeuVax™ vaccine;   Biological: Leukine® (sargramostim, GM-CSF) and water for injection
2 Completed Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer
Condition: Breast Cancer
Intervention: Biological: E75 + GM-CSF vaccine
3 Completed Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients
Condition: Breast Cancer
Intervention: Biological: E75 + GM-CSF vaccine

Indicates status has not been verified in more than two years